MDV, Thanks for the reply. I have read a bit ab
Post# of 148174
Thanks for the reply. I have read a bit about maraviroc and believed that Leronlimab as a competitive receptor site blocker is postulated to have a different effect that the non-competitive, allosteric modulating medications.
Of course I am parroting what I have read elsewhere.
What are your thoughts?